Open Access
Copyright: The authors. This article is an open access
article licensed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/2.0) which permits unrestricted use,
distribution and reproduction in any medium, provided the work is properly
cited.
Review Article
20.
Nanobiotechnology: A voyage to
future? -
Biswa Ranjan Maharana, Manjit Panigrahi, Rubina
Kumari Baithalu and Subhashree Parida
Vet World. 2010; 3(3): 145-147
Abstract
Nanobiotechnology is an emerging field that is
potentially changing the way we treat diseases
through drug delivery and tissue engineering.
Methods of targeting nanoparticles to specific sites
of the body while avoiding capture by vital organs
are major hurdles that need to be answered. Whether
actual or perceived, the potential health hazards
associated with the production, distribution and use
of nanomaterial must be balanced by the overall
benefit that nanobiotech-nology has to offer
biomedical science such as therapeutic and
diagnostic applications. It would be difficult to
deny the potential benefits of nanobiotechnology and
stop development of research related to it since it
has already begun to penetrate many different fields
of research. However, nanobiotechnology can be
developed using guidelines to insure that the
technology does not become too potentially harmful.
As Richard Feynmann has rightly predicted that
“There is plenty of room at the bottom” to modify
and enhance existing technologies by manipulating
material properties at the nanoscale, therefore with
sufficient time and research nanobiotechnology based
early detection, diagnosis and treatment of various
diseases may become a reality. Nanobiotechnology may
bring immense paradigm shift that we would wonder
that how did we live without it?
Keywords: Biotechnology, Drug delivery, In
vivo, In vitro, Diagnosis, Toxicity, Tissue
Engineeering.
